IRIS - Res&Arch Institutional Research Information System - Research & Archive

ROSATI, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.432
EU - Europa 3.094
AS - Asia 2.246
SA - Sud America 412
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 9.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.370
SG - Singapore 979
IT - Italia 574
IE - Irlanda 531
SE - Svezia 501
UA - Ucraina 410
BR - Brasile 366
HK - Hong Kong 366
CN - Cina 349
VN - Vietnam 280
RU - Federazione Russa 277
DE - Germania 237
FI - Finlandia 194
KR - Corea 101
GB - Regno Unito 98
FR - Francia 50
RO - Romania 45
TR - Turchia 37
IN - India 36
PL - Polonia 33
BE - Belgio 30
CA - Canada 29
AT - Austria 24
MX - Messico 24
NL - Olanda 20
JP - Giappone 19
UZ - Uzbekistan 18
AR - Argentina 15
CZ - Repubblica Ceca 15
ES - Italia 15
CH - Svizzera 13
EC - Ecuador 13
ZA - Sudafrica 13
BD - Bangladesh 12
GR - Grecia 10
MA - Marocco 9
ID - Indonesia 8
LT - Lituania 8
EU - Europa 7
IQ - Iraq 6
LB - Libano 6
CI - Costa d'Avorio 5
PE - Perù 5
PY - Paraguay 5
AZ - Azerbaigian 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CO - Colombia 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
PK - Pakistan 3
AM - Armenia 2
AO - Angola 2
CL - Cile 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
QA - Qatar 2
VE - Venezuela 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CR - Costa Rica 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
GT - Guatemala 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LY - Libia 1
NG - Nigeria 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 9.234
Salva come PNG Salva come JPEG
Città #
Singapore 661
Chandler 581
Dublin 531
Hong Kong 366
San Mateo 341
Perugia 230
Ashburn 202
Dong Ket 175
Boardman 163
Jacksonville 155
Ann Arbor 143
Santa Clara 141
Medford 107
Princeton 106
Seoul 101
Munich 94
Beijing 88
Moscow 82
Wilmington 82
Altamura 69
Andover 69
Los Angeles 53
Des Moines 51
Helsinki 51
Lawrence 49
Turku 44
New York 41
Bucharest 40
Ho Chi Minh City 40
Saint Petersburg 40
Woodbridge 36
Piscataway 34
São Paulo 32
Brussels 30
Dallas 24
Norwalk 21
Warsaw 21
The Dalles 20
Tokyo 19
Izmir 18
Hanoi 17
Houston 17
Brooklyn 15
Dearborn 15
Falls Church 15
Foligno 14
Belo Horizonte 13
Frankfurt am Main 13
Milan 13
Rome 13
Vienna 13
Council Bluffs 12
Curitiba 11
San Francisco 11
Toronto 11
Guangzhou 10
Hefei 10
London 10
Shanghai 10
Assisi 9
Boston 9
Falkenstein 9
Rio de Janeiro 9
Amsterdam 8
Chennai 8
Johannesburg 8
Mexico City 8
Porto Alegre 8
Redwood City 8
San Paolo di Civitate 8
Stockholm 8
Tavernelle 8
Ankara 7
Atlanta 7
Auburn Hills 7
Columbus 7
Denver 7
Poplar 7
Tashkent 7
Biên Hòa 6
Brno 6
Olomouc 6
Ottawa 6
Pescara 6
Piediluco 6
Salvador 6
Shijiazhuang 6
Abidjan 5
Charlotte 5
Da Nang 5
Den Haag 5
Denizli 5
Florence 5
Manchester 5
Montreal 5
Orem 5
Phoenix 5
Quito 5
Redmond 5
Seattle 5
Totale 5.664
Salva come PNG Salva come JPEG
Nome #
Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago 218
Activity inhibition of cytolytic lymphocytes by omeprazole. 163
Activation of cytokine genes during primary and anamnestic immune response to inactivated C. albicans 157
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 157
Local and systemic immune response to inactivated C. albicans in mice 150
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 146
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 142
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 141
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 133
Cytokine response to inactivated Candida albicans in mice 131
Group B Streptococcus induces apoptosis in macrophages 128
Macrophage induced gelsolin in response to Group B Streptococcus (GBS) infection 127
Experimental model of type IV Streptococcus agalactiae (Group B streptococcus) infection in mice with development of septic arthritis. 126
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 124
Cytokine response to group B streptococcus infection in mice 117
Regolazione redox dell'apoptosi di linfociti B umani. 115
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 114
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 113
Graft engineering for allogeneic haploidentical stem cell transplantation 113
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 110
Cytokine gene expression during in vivo induction of natural killer/lymphokine activated killer cells by inactivated C. albicans cells 109
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 109
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 108
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 108
Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages 107
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 106
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 106
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 106
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 104
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 104
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 104
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 102
In vitro effects of Meropenem and Imipenem/Cilastatin on some functions of human natural effector cells 101
Citochine nella risposta immune primaria e secondaria verso la C. albicans inattivata 101
Local and systemic immune response to inactivated Candida Albicans in mice. 98
Silica particle size and shape: in vitro effects on extracellular matrix metabolism and viability of human bronchial epithelial cells. 96
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 96
L’N-Acetil-L-cisteina inibisce l’apoptosi di linfociti B umani regolando l’attivazione di diverse vie di trasduzione del segnale 93
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. 92
Inibizione della attività NK da parte dell’omeprazolo 92
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 91
Is thiol supplementation for potentiang antioxidant defenses a harmless strategy? 90
Citochine infiammatorie in risposta alla C. albicans inattivata 90
B-chronic lymphocytic leukemia cells exert in vitro cytotoxicity mediated by tumor necrosis factor alpha. 89
Correlazione fra la induzione nel topo della espressione genica di citochine da parte della C. albicans inattivata ed attivazione di cellule NK/LAK 86
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 85
In vivo generation of LAK-like cells by inactivated Candida albicans cells. 85
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 85
Espressione di geni per le citochine ed attivazione di cellule NK/LAK da parte della C. albicans inattivata 84
Cytokine gene expression during primary and anamnestic immune response to inactivated C. albicans 84
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C.albicans hyphae in vitro. 84
Eventi immunologici precoci nella risposta immune alla C. albicans inattivata 83
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 82
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 82
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 81
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 81
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 80
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 78
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function. 78
Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. 77
Group B streptococci persist inside macrophages. 77
Macrophage apoptosis induced by Group B Streptococcus 77
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 76
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 72
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. 72
Cytokine response to group B streptococcus infection in mice 72
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 71
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 69
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 68
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection. 68
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 67
Artrite cronica sperimentale indotta nel topo mediante infezione sistemica con Streptococco di Gruppo B, Sierotipo IV 65
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 64
Inhibition activity of human cytolytic lymphocytes in vitro by omeprazole 64
Impairment of brain mitochondrial functions by ß-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine. 64
Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine 64
Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans. 62
C. albicans cell wall components as inducers of LAK-like cells in mice 62
Experimental septic arthritis induced by type IV Group B Streptococcus in mice. 61
Natural mechanism of resistance to Group B Streptococcus (GBS) type Ia infection in mice. 61
In vivo modulation of lymphokine-activated killer cell activity by cell wall components of candida albicans. 61
Una mannoproteina parietale di C. albicans come modulatore in vivo dell'attività delle cellule NK/LAK 61
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 59
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 58
Persistent in vivo activation of NK/LAK cells by inactivated C. albicans and its mannoprotein fraction 58
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 58
Immunomodulatory activity of C. albicans and its cell wall components on LAK-like cells induction in mice. 57
Pathogenic effects of group B streptococcus on macrophages 57
Septic arthritis induced in mice by systemic infection with different serotypes of Group B Streptococci (GBS). 55
Omeprazole inhibition of natural killer cytotoxicity 55
Inibizione in vitro dell’attività citotossica dei linfociti citolitici da parte dell’omeprazolo 54
Modulazione in vivo dell’attività NK/LAK mediante una mannoproteina parietale di C. albicans 53
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 52
NOTCH and Graft-Versus-Host Disease 52
Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation 50
Componenti di parete della C. albicans come induttori di cellule NK e LAK 49
Una mannoproteina di parete di C. albicans come modulatore in vivo dell’attività delle cellule NK/LAK 45
Patogenicità nel topo di diversi ceppi di Streptococcus di Gruppo B Sierotipo IV 45
Induzione di effettori della citotossicità naturale da parte della C. albicans: confronto con altri immunomodulatori 43
Produzione in vivo di citochine da parte della C. albicans inattivata ed induzione di cellule NK/LAK 42
Totale 8.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.082
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021580 0 0 0 0 0 93 51 4 108 52 65 207
2021/20221.217 51 287 21 109 49 12 16 293 18 57 125 179
2022/20231.734 117 238 13 181 154 199 13 86 652 0 51 30
2023/2024712 35 79 48 28 4 20 189 23 65 18 87 116
2024/20251.762 45 158 67 96 221 82 77 118 336 84 322 156
2025/20261.851 259 245 219 497 519 112 0 0 0 0 0 0
Totale 9.510